This report contains 147 pages, 17 tables and presents a comprehensive analysis of the US flow cytometry market, including:
- Major issues pertaining to the US flow cytometry practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
- Five-year volume and sales forecasts for major flow cytometry tests performed in US hospitals and commercial laboratories.
- Annual placements and installed base of major flow cytometers.
- Review of current instrumentation technologies and a feature comparison of leading systems.
- Five-year reagent and instrument sales forecasts.
- Sales and market shares of leading reagent and instrument suppliers.
- Review of current and emerging diagnostic technologies, and their potential market applications.
- Product development opportunities for new instruments, consumables, and auxiliary products.
- Profiles of current and emerging suppliers, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and corporate strategies.
- Business opportunities and strategic recommendations for suppliers.
Table of Contents
I. IntroductionII. Worldwide Market and Technology Overview
A. Major Flow Cytometry Applications
1. Cell Surface Markers
a. Lymphocyte Subclassification CD4/CD8
° Instrumentation and
Reagent Test Kits
- BD FACS Count
- Beckman Coulter VCS
- T Cells Diagnostics TRAx
b. Other Cell Markers
2. DNA Content Analysis
3. RNA Content Analysis
4. Chemotherapy Monitoring
5. Cell Cycle Analysis
6. Reticulocytes
7. Chromosome Analysis
8. Fetal Cell Analysis
9. HLA Typing
10. Microbiology
11. Protein Content Analysis
12. Multiparameter Analysis
13. Other Applications
B. Instrumentation Review
a. Introduction
b. System Overview
° BD FACSadvantage
° BD FACSAria III
° BD FACSCalibur
° BD FACScan
° BD FACSCanto II
° BD FACSCount
° BD FACSort
° BD FACStar Series
° BD FACStrak
° BD FACS Vantage
° BD Influx
° Beckman Coulter Epics C
° Beckman Coulter Epics Elite Analyzer
° Beckman Coulter Epics Elite ESP
° Beckman Coulter Epics Profile
° Beckman Coulter Epics XL
° Beckman Coulter FC 500 Series
° Beckman Coulter Vi-CELL XR
C. Current Market Needs and Future Demand for
Hematology Analyzers
D. Reagents and Controls
E. Current and Emerging Technologies
1. Information Technologies
2. Automation and Robotics
3. Lasers
4. Artificial Intelligence
5. Monoclonal Antibodies
6. Molecular Diagnostics
7. Microdrop Technology
III. U.S.
A. Executive Summary
B. Business Environment
1. Health Care Expenditures
2. Cost Consciousness
3. Reimbursement
4. Industry Consolidation
5. Managed Care
a. HMO
b. PPO
6. Hospitals
7. Admissions
8. Length of Stay
9. Industry Diversification
10. Physician Demographics
11. Population Aging
a. Chronic Illness
b. Disease Incidence
c. Susceptibility to Iatrogenesis
d. Multiple Illness Cases
12. Laboratory Regulations
C. Market Structure
D. Market Size, Growth and Major Suppliers’
Instrument Placements, Installed Base, Sales
and Market Share
IV. Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Information Technology
D. Auxiliary Products
V. Design Criteria for Decentralized Testing Products
VI. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for the Decentralized
Testing Markets
1. Four Marketing Approaches
2. Product Complexity Factor
3. Customer Preference Factor
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation Factor
VII. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VIII. Competitive Assessments
° Abbott
° Agilent Technologies
° Beckman Coulter/Danaher
° Becton Dickinson
° Bio-Rad
° Horiba
° Iris Diagnostics/Danaher
° Nihon Kohden
° Ortho-Clinical Diagnostics
° Roche
° Siemens
° Sysmex
IX. Appendix: Major Universities and Research
Centers Developing Hematology/Flow Cytometry
Technologies and Applications
List of Tables
U.S., Laboratories Performing
Hematology/Flow Cytometry Tests
By Market Segment
U.S., Hospital Laboratories Performing
Hematology/Flow Cytometry Tests By Bed Size
U.S., Commercial/Private Laboratories
Performing Hematology/Flow Cytometry Tests
By Annual Test Volume
U.S., Physician Offices/Group Practices
Performing Hematology/Flow Cytometry Tests
By Practice Size
U.S., Total Flow Cytometry and Special
Hematology Specimen Volume Forecast By Market Segment
U.S., Total Flow Cytometry and Special
Hematology Specimen Volume Forecast
U.S., All Market Segments Flow Cytometry and
Special Hematology Test Volume Forecast
U.S., Hospital Laboratories, Flow Cytometry and
Special Hematology Test Volume Forecast
U.S., Commercial/Private Laboratories, Flow Cytometry
And Special Hematology Test Volume Forecast
U.S., Physician Office Laboratories, Flow Cytometry
And Special Hematology Test Volume Forecast
U.S., Major Flow Cytometers, Estimated
Placements and Installed Base
U.S., Total Flow Cytometry Diagnostics Market
Forecast By Market Segment
U.S., Flow Cytometry Instrument Market Forecast
By Market Segment
U.S., Flow Cytometry Consumable Market Forecast
By Market Segment
U.S., Total Flow Cytometry Diagnostics Market
By Major Supplier
U.S., Total Flow Cytometry Instrument Market
By Major Supplier
U.S., Total Flow Cytometry Consumables Market
By Major Supplier
Companies Mentioned
- Abbott
- Agilent Technologies
- Beckman Coulter/Danaher
- Becton Dickinson
- Bio-Rad
- CellaVision
- Horiba
- Nihon Kohden
- Ortho-Clinical Diagnostics
- Roche
- Siemens Healthineers
- Sysmex
